Meta-Analysis: Pharmacological Treatment of Arterial Hypertension in Children and Adolescents
3 Aug, 2018 | 02:54h | UTCCommentary: Pediatric hypertension: ACEi/ARBs look like the best choice – Univadis (free)
“According to the present analysis, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers could represent the best choice as antihypertensive treatment for pediatric hypertension. However, because of the paucity of available data for the other classes of antihypertensive drugs, definitive conclusions are not allowed and further randomized controlled trials are warranted.”